Patents by Inventor John G. Curd

John G. Curd has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of Chronic Lymphocytic Leukemia using Anti-CD20 Antibodies
    Publication number: 20100080769
    Abstract: Chronic Lymphocytic Leukemia (CLL) may be treated with antibodies directed against the CD20 antigen.
    Type: Application
    Filed: December 2, 2009
    Publication date: April 1, 2010
    Applicants: BIOGEN IDEC INC., GENENTECH, INC.
    Inventors: Antonio J. Grillo-Lopez, Christine A. White, John G. Curd, Susan Desmond-Hellmann
  • Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody
    Patent number: 7682612
    Abstract: Chronic Lymphocytic Leukemia (CLL) may be treated with antibodies directed against the CD20 antigen.
    Type: Grant
    Filed: November 9, 1999
    Date of Patent: March 23, 2010
    Assignees: Biogen Idec Inc., Genentech, Inc.
    Inventors: Christine A. White, Antonio J. Grillo-López, John G. Curd, Susan Desmond-Hellmann
  • Prevention and Treatment of Gastrointestinal and Bladder Disorders Associated with Chemotherapy or Radiation Therapy Using Active Vitamin D Compounds
    Publication number: 20090163453
    Abstract: The present invention relates to a method for preventing, treating, or ameliorating gastrointestinal and bladder disorders in a patient receiving a chemotherapy or radiation therapy comprising administering to the patient a therapeutically effective amount of active vitamin D compound or a mimic thereof. According to the invention, the active vitamin D compound or a mimic thereof may be administered by high dose pulse administration so that high doses of the active vitamin D compound or a mimic thereof can be administered to an animal without inducing severe symptomatic hypercalcemia.
    Type: Application
    Filed: September 26, 2006
    Publication date: June 25, 2009
    Applicant: Novacea Inc.
    Inventors: John G. Curd, Bradford S. Goodwin, Jeffrey L. Cleland
  • Treatment, prevention and amelioration of pulmonary disorders associated with chemotherapy or radiotherapy with active vitamin D compounds or mimics thereof
    Publication number: 20090069276
    Abstract: The present invention relates to a method for preventing, treating or ameliorating pulmonary disorders in a patient receiving a chemotherapeutic or radiotherapeutic agent or treatment comprising administering to the patient a pharmaceutical composition comprising an effective amount of active vitamin D compound or a mimic thereof. According to the invention, the active vitamin D compound, or the mimic thereof, may be administered by HDPA so that high doses of the active vitamin D compound can be administered to an animal without inducing severe symptomatic hypercalcemia.
    Type: Application
    Filed: April 24, 2006
    Publication date: March 12, 2009
    Applicant: Novacea, Inc.
    Inventors: John G. Curd, Bradford S. Goodwin, Jeffrey L. Cleland
  • Treatment of Hyperproliferative Diseases with Vinca Alkaloid N-Oxide and Analogs
    Publication number: 20080305075
    Abstract: The present invention relates to vinca alkaloid and analog N-oxides having activity for treating hyperproliferative disorders. Further, the invention relates to pharmaceutical compositions and methods of using vinca alkaloid and analog N-oxides, alone or in combination with one or more other active agents or treatments, to treat hyperproliferative disorders.
    Type: Application
    Filed: April 29, 2008
    Publication date: December 11, 2008
    Inventors: John G. Curd, John F.W. Keana, Alshad S. Lalani, Paul B. Westberg, Bradford Goodwin, W. David Henner
  • 1,4-Bis-N-Oxide-5,8- Dihydroxyanthracenedione Compounds and the Use Thereof
    Publication number: 20080305082
    Abstract: Disclosed are compounds having Formula I: and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, A, and B are as defined herein, for use in methods for treating, preventing or ameliorating hyperproliferative disorders, such as cancer and other diseases and conditions. The invention also relates to pharmaceutical compositions and formulations comprising a compound having Formula I, and in combination with one or more other active agents and/or treatments.
    Type: Application
    Filed: September 14, 2005
    Publication date: December 11, 2008
    Inventors: John G. Curd, Robert L. Capizzi, John F.W. Keana